ImmunSYS Competitors and Similar CompaniesClear all
ImmunSYS's competitors and similar companies include Plus Therapeutics, TME Pharma and OncoImmune.
 Plus Therapeutics Plus Therapeutics is a pharmaceutical company focused on the development of treatments for patients battling cancer and other life-threatening diseases. |  TME Pharma TME Pharma (formerly known as NOXXON Pharma) is a clinical-stage biopharmaceutical company that focuses on the development of proprietary therapeutics for the treatment of cancer. |  OncoImmune OncoImmune is a clinical-stage biopharmaceutical company engaged in the discovery and development of biopharmaceuticals for the treatment of cancer and autoimmune disease. | ||
Founding Date | Founding Date 2018 | Founding Date 1996 | Founding Date 1998 | Founding Date 2000 |
Type | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Fort Lauderdale, US HQ | Locations Austin, US HQ San Antonio, US | Locations Berlin, DE HQ | Locations Rockville, US HQ |
Employees | Employees 1 | Employees 1721% increase | Employees 12 | Employees 9 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 8 m | Valuation ($) 6.6 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $5.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($22.4m) (FY, 2025) | Net income (€3.3m) (FY, 2025) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 71.9m | Total funding raised $ 110.9m | Total funding raised $ 71.8m |
For sources of this data, please see the company profile
View Company Profiles
Plus Therapeutics
HQ
Austin, US
Employees
17↑ 21% increase
Plus Therapeutics is a pharmaceutical company focused on the development of treatments for patients battling cancer and other life-threatening diseases.
View companyTME Pharma
HQ
Berlin, DE
Employees
12
TME Pharma (formerly known as NOXXON Pharma) is a clinical-stage biopharmaceutical company that focuses on the development of proprietary therapeutics for the treatment of cancer.
View companyOncoImmune
HQ
Rockville, US
OncoImmune is a clinical-stage biopharmaceutical company engaged in the discovery and development of biopharmaceuticals for the treatment of cancer and autoimmune disease.
View company